159 related articles for article (PubMed ID: 8213583)
41. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
[TBL] [Abstract][Full Text] [Related]
42. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
[TBL] [Abstract][Full Text] [Related]
44. Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.
Jacotot B; Benghozi R; Pfister P; Holmes D
Am J Cardiol; 1995 Jul; 76(2):54A-56A. PubMed ID: 7604799
[TBL] [Abstract][Full Text] [Related]
45. Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin. The LIPID Study Investigators.
Stewart RA; Sharples KJ; North FM; Menkes DB; Baker J; Simes J
Arch Intern Med; 2000 Nov; 160(20):3144-52. PubMed ID: 11074745
[TBL] [Abstract][Full Text] [Related]
46. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
47. Primary prevention of cardiovascular diseases among hypercholesterolemic Japanese with a low dose of pravastatin.
Nakamura H;
Atheroscler Suppl; 2007 Aug; 8(2):13-7. PubMed ID: 17586102
[TBL] [Abstract][Full Text] [Related]
48. Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a.
Hunninghake DB; Stein EA; Mellies MJ
J Clin Pharmacol; 1993 Jun; 33(6):574-80. PubMed ID: 8366183
[TBL] [Abstract][Full Text] [Related]
49. The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
Glasser SP; DiBianco R; Effron BA; Faas F; Germino FW; Shane LE; Unger AH; Staggers JE
Am J Cardiol; 1996 Jan; 77(1):83-5. PubMed ID: 8540464
[TBL] [Abstract][Full Text] [Related]
50. Long-term effects of pravastatin on serum lipid levels in elderly patients with hypercholesterolemia.
Morimoto S; Koh E; Fukuo K; Higaki J; Ikegami H; Miki T; Hata T; Ogihara T
Clin Ther; 1994; 16(5):793-803. PubMed ID: 7859238
[TBL] [Abstract][Full Text] [Related]
51. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.
Nakamura H; Arakawa K; Itakura H; Kitabatake A; Goto Y; Toyota T; Nakaya N; Nishimoto S; Muranaka M; Yamamoto A; Mizuno K; Ohashi Y;
Lancet; 2006 Sep; 368(9542):1155-63. PubMed ID: 17011942
[TBL] [Abstract][Full Text] [Related]
52. Once-daily pravastatin in patients with primary hypercholesterolemia: a dose-response study.
Jones PH; Farmer JA; Cressman MD; McKenney JM; Wright JT; Proctor JD; Berkson DM; Farnham DJ; Wolfson PM; Colfer HT
Clin Cardiol; 1991 Feb; 14(2):146-51. PubMed ID: 1904333
[TBL] [Abstract][Full Text] [Related]
53. Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project.
Pfeffer MA; Keech A; Sacks FM; Cobbe SM; Tonkin A; Byington RP; Davis BR; Friedman CP; Braunwald E
Circulation; 2002 May; 105(20):2341-6. PubMed ID: 12021218
[TBL] [Abstract][Full Text] [Related]
54. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study.
Izawa A; Kashima Y; Miura T; Ebisawa S; Kitabayashi H; Yamamoto H; Sakurai S; Kagoshima M; Tomita T; Miyashita Y; Koyama J; Ikeda U;
Circ J; 2015; 79(1):161-8. PubMed ID: 25392071
[TBL] [Abstract][Full Text] [Related]
55. Comparative efficacy and tolerability of 5 and 10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia. Simvastatin Pravastatin European Study Group.
Steinhagen-Thiessen E
Cardiology; 1994; 85(3-4):244-54. PubMed ID: 7987882
[TBL] [Abstract][Full Text] [Related]
56. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).
Jukema JW; Bruschke AV; van Boven AJ; Reiber JH; Bal ET; Zwinderman AH; Jansen H; Boerma GJ; van Rappard FM; Lie KI
Circulation; 1995 May; 91(10):2528-40. PubMed ID: 7743614
[TBL] [Abstract][Full Text] [Related]
57. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
[TBL] [Abstract][Full Text] [Related]
58. Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M
Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796
[TBL] [Abstract][Full Text] [Related]
59. A coronary primary intervention study of Japanese men: study design, implementation and baseline data. The Kyushu Lipid Intervention Study Group.
J Atheroscler Thromb; 1996; 3(2):95-104. PubMed ID: 9226461
[TBL] [Abstract][Full Text] [Related]
60. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris.
Am J Cardiol; 1995 Sep; 76(7):474-9. PubMed ID: 7653447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
